Loading
RPL10 (Large ribosomal subunit protein uL16) is a gene that drives cell growth when it is altered. The public catalogues list it as a drug target and an oncogene driver, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Non-Hodgkin lymphoma, Multiple myeloma, Leukaemia and 1 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
Component of the large ribosomal subunit. Plays a role in the formation of actively translating ribosomes. May play a role in the embryonic brain development. Location: Cytoplasm (UniProt). Locus Xq28 (HGNC).
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"RPL10" OR ABSTRACT:"RPL10" OR TITLE:"ribosomal protein L10" OR ABSTRACT:"ribosomal protein L10" OR TITLE:"Large ribosomal subunit protein uL16" OR ABSTRACT:"Large ribosomal subunit protein uL16" OR TITLE:"DXS648E" OR ABSTRACT:"DXS648E" OR TITLE:"DXS648" OR ABSTRACT:"DXS648" OR TITLE:"FLJ23544" OR ABSTRACT:"FLJ23544") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about RPL10, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/rpl10.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/rpl10.json. Licence CC BY-NC 4.0.